Drugs / 50% N2O plus 50% O2
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06636357 Background | Jan 2025 → Sep 2026 overdue | electroencephalographic peculiarity: fronto-precentral beta wave groups, hair anomaly | University of Zurich | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 50% N2O plus 50% O2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06636357 ↗ |
| Route | Inhaled | “Inhalation of 50% N2O plus 50% O2 for 45 min” NCT06636357 ↗ |